Genetic Abnormality Linked To Pediatric Cancer Risk

Researchers at the Children's Cancer Institute identified a specific genetic change present in one in six children with cancer. This discovery helps explain why certain children develop cancer despite the absence of common environmental factors like tobacco or sunlight. The study involved enrolling all children with cancer in the program to identify these specific genetic markers. Clinicians may currently miss these diagnoses because they rely on classical testing criteria that do not account for these specific genetic variations. The research suggests a broader approach to genetic testing is necessary to understand pediatric oncology causes. Patients with these abnormalities may require more intensive screening plans following initial cancer survival. Genetic variants may increase the risk of severe toxicities and second cancers in children undergoing chemotherapy. Medical professionals use this information to mitigate risks during treatment. These genetic changes can be inherited from either the mother or the father. Identifying these changes in a child allows for the screening of parents and relatives who may also carry the risk. The discovery aims to mitigate toxicity risks and improve early detection through family screening. New details confirm the genetic changes are inheritable from either parent and can be used to trigger cancer screening for relatives.